We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Specific Gut Bacterium Linked to Irritable Bowel Syndrome

By LabMedica International staff writers
Posted on 08 Dec 2020
Print article
Image: Appearance of a `false brush border` of Brachyspira pilosicoli cells attached by one cell end to the luminal surface of human colonic enterocytes in a patient diagnosed with human intestinal spirochetosis (Photo courtesy of David J. Hampson, PhD, DSc).
Image: Appearance of a `false brush border` of Brachyspira pilosicoli cells attached by one cell end to the luminal surface of human colonic enterocytes in a patient diagnosed with human intestinal spirochetosis (Photo courtesy of David J. Hampson, PhD, DSc).
The incidence of Irritable Bowel Syndrome (IBS) steeply increases following a gastroenteritis episode, suggesting a possible causative role for microbial perturbation. Gut microbiota composition studies overwhelmingly rely on fecal material.

Fecal and mucus-associated bacteria represent distinctive populations, with the latter more likely to influence the epithelium. In particular, bacterial presence in the inner mucus layer might result in epithelial stress and immune activation. Analyses of fecal microbiota have not demonstrated consistent alterations in IBS.

Biomedical scientists at the University of Gothenburg (Gothenburg, Sweden) and their colleagues prospectively included 62 IBS patients and 31 normal controls that underwent sigmoidoscopy with sampling of biopsies in methanol-Carnoy for future histology/immunohistochemistry and real-time PCR analysis. In a randomly selected subset of participants (the first/explorative cohort, IBS n=22, healthy n=14), mucus was collected from ex vivo sigmoid colon biopsies and analyzed by mass spectrometry (MS).

Mucus samples were prepared for MS according to a modified version of the Filter-Aided Sample Preparation (FASP) protocol. Nano-liquid chromatography-tandem MS was performed on a Q-Exactive instrument (Thermo Fisher Scientific, Bremen, Germany). Histology and immunohistochemistry was performed on tissue sections. Sections were examined using an Eclipse E-1000 epifluorescent microscope (Nikon, Tokyo, Japan). All PCR reactions were carried out in triplicate, using a Bio-Rad CFX96 Real-Time System (Bio-Rad, Hercules., CA, USA).

The investigators reported that metaproteomic analysis of colon mucus samples identified peptides from potentially pathogenic Brachyspira species in a subset of patients with IBS. Using multiple diagnostic methods, mucosal Brachyspira colonization was detected in a total of 19/62 (31%) patients with IBS from two prospective cohorts, versus 0/31 healthy volunteers. The prevalence of Brachyspira colonization in IBS with diarrhea (IBS-D) was 40% in both cohorts. Brachyspira attachment to the colonocyte apical membrane was observed in 20% of patients with IBS and associated with accelerated oro-anal transit, mild mucosal inflammation, mast cell activation and alterations of molecular pathways linked to bacterial uptake and ion–fluid homeostasis. According to species discrimination by real-time PCR, 50% of patients with spirochetosis were colonized by B. pilosicoli; others had either B. aalborgi or the closely related, unconfirmed, species B. hominis.

Magnus Simrén, MD, PhD, a Professor of Gastroenterology, and a co-author of the study, said, “The study suggests that the bacterium may be found in about a third of individuals with IBS. We want to see whether this can be confirmed in a larger study, and we're also going to investigate whether, and how, Brachyspira causes symptoms in IBS. Our findings may open up completely new opportunities for treating and perhaps even curing some IBS patients, especially those who have diarrhea.”

The authors concluded that mucosal Brachyspira colonization was significantly more common in IBS and associated with distinctive clinical, histological and molecular characteristics. The observations suggest a role for Brachyspira in the pathogenesis of IBS, particularly IBS-D. The study was published on November 11, 2020 in the journal GUT.

Related Links:
University of Gothenburg
Thermo Fisher Scientific
Nikon
Bio-Rad


Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Vaginitis Test
Allplex Vaginitis Screening Assay
New
Myeloperoxidase Assay
IDK MPO ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.